Hospitals AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee byJosh SandbergMarch 9, 2018
Biologics Hospitals Top Stories MiMedx Notified By FDA That It Can Proceed With Phase 2B Investigational New Drug Clinical Trial For Osteoarthritis Of The Knee byJosh SandbergOctober 17, 2017
Biologics Hospitals Top Stories MiMedx Files With The FDA To Initiate The Company’s Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee byJosh SandbergSeptember 19, 2017
